study design (FPG cut-off(s): and/or OGT (FPG and/ or OGT Araneta () Level III-2 Risk of bias N=933 Excluded individuals with known California unclear due to Americans, diabetes. Cross-sectional and poor Japanese-Americans, study of ethnic Hawaii, reporting. native Hawaiians; minorities recruited USA mean age 54.2 years, from community. Limited 27% male. applicability due to ethnic minorities not applicable to Australia. Appropriate cut-off points. Wang, H () Level III-2 Risk of bias American Indians Excluded people with CVD; at follow 5.5%≥ HbA1c 5.6 mmol/L≥ FPG 3x3 table and Wang, unclear as from Arizona, up, excluded people with diabetes HbA1c ≥6.5% FPG ≥7.0 Baseline and W () Four selection of Oklahoma, North and diagnosed at baseline. <6.5% <7.0 mmol/L follow-up measures states of population not South Dakota. of subjects in large 6.0%≥ USA described and Baseline n=3850, cohort study of HbA1c people with follow-up n=1670. heard disease. <6.5% CVD Age range excluded. years. Limited applicability due to ethnic minority, not relevant to Australia. Appropriate cut-off points. Exebio () Level III-2 Risk of bias Patients of Haitian Excluded people less than 35 years Not Not Not reported FPG ROC unclear as origin (2 Haitian of age, and pregnant and reported reported ≥7.0 analysis Florida, Cross-sectional patient parents), n=128, all breastfeeding women, n=1 who had analysis of control USA recruitment aged 35 years or missing HbA1c value. arm of patients
study design (FPG and/or OGT cut-off(s): (FPG and/ or OGT Araneta () California and Hawaii, USA Level III-2 Cross-sectional study of ethnic minorities recruited from community. Risk of bias unclear due to poor reporting. Limited applicability due to ethnic minorities not applicable to Australia. Appropriate cut-off points. N=933 Japanese-Americans, native Hawaiians; mean age 54.2 years, 27% male. Excluded individuals with known diabetes. Wang, H () and Wang, W () Four states of USA Level III-2 Baseline and follow-up measures of subjects in large cohort study of heard disease. Risk of bias unclear as selection of population not described and people with CVD excluded. Limited applicability due to ethnic minority, not relevant to Australia. Appropriate cut-off points. American Indians from Arizona, Oklahoma, North and South Dakota. Baseline n=3850, follow-up n=1670. Age range years. Excluded people with CVD; at follow up, excluded people with diabetes diagnosed at baseline. 5.5%≥ HbA1c <6.5% 6.0%≥ HbA1c <6.5% HbA1c ≥6.5% 5.6 mmol/L≥ FPG <7.0 mmol/L FPG ≥7.0 3x3 table Exebio () Florida, USA Level III-2 Cross-sectional analysis of control arm of patients Risk of bias unclear as patient recruitment Patients of Haitian origin (2 Haitian parents), n=128, all aged 35 years or Excluded people less than 35 years of age, and pregnant and breastfeeding women, n=1 who had missing HbA1c value. Not reported Not reported Not reported FPG ≥7.0 ROC analysis Americans,
1267-FinalContractedAssessmentReport-accessible.DOCX